PubMed

Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

Meyer JM, McEvoy JP, Davis VG, Goff DC, Nasrallah HA, Davis SM, Hsiao JK, Swartz MS, Stroup TS, Lieberman JA.

Biol Psychiatry. 2009 Dec 1;66(11):1013-22. Epub 2009 Jul 29.PMID: 19640511 [PubMed - in process]Related articles

Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

Patel JK, Buckley PF, Woolson S, Hamer RM, McEvoy JP, Perkins DO, Lieberman JA, CAFE Investigators.

Schizophr Res. 2009 Jun;111(1-3):9-16. Epub 2009 Apr 26.PMID: 19398192 [PubMed - indexed for MEDLINE]Related articles

Much ado about small differences.

McEvoy JP.

World Psychiatry. 2009 Feb;8(1):29-30. No abstract available. PMID: 19293953 [PubMed - in process]Related articlesFree article

Linkage analysis of schizophrenia in African-American families.

Wiener HW, Klei L, Irvin MD, Perry RT, Aliyu MH, Allen TB, Bradford LD, Calkins ME, Devlin B, Edwards N, Gur RE, Gur RC, Kwentus J, Lyons PD, McEvoy JP, Nasrallah HA, Nimgaonkar VL, O'Jile J, Santos AB, Savage RM, Go RC.

Schizophr Res. 2009 Apr;109(1-3):70-9. Epub 2009 Mar 5.PMID: 19264455 [PubMed - indexed for MEDLINE]Related articles

A genome-wide investigation of SNPs and CNVs in schizophrenia.

Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciūte D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, McEvoy JP, Keefe RS, Fisher EM, St Jean PL, Giegling I, Hartmann AM, Möller HJ, Ruppert A, Fraser G, Crombie C, Middleton LT, St Clair D, Roses AD, Muglia P, Francks C, Rujescu D, Meltzer HY, Goldstein DB.

PLoS Genet. 2009 Feb;5(2):e1000373. Epub 2009 Feb 6. Erratum in: PLoS Genet. 2009 Mar;5(3). doi: 10.1371/annotation/e0196ebb-de40-453f-8f8c-791b126618da. PMID: 19197363 [PubMed - indexed for MEDLINE]Related articlesFree article

Computational studies of the O(2)-evolving complex of photosystem II and biomimetic oxomanganese complexes.

Sproviero EM, Gascón JA, McEvoy JP, Brudvig GW, Batista VS.

Coord Chem Rev. 2008 Feb;252(3-4):395-415.PMID: 19190716 [PubMed]Related articlesFree article

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.

Need AC, Keefe RS, Ge D, Grossman I, Dickson S, McEvoy JP, Goldstein DB.

Eur J Hum Genet. 2009 Jul;17(7):946-57. Epub 2009 Jan 21.PMID: 19156168 [PubMed - indexed for MEDLINE]Related articles

The impact of obesity on health care costs among persons with schizophrenia.

Chwastiak LA, Rosenheck RA, McEvoy JP, Stroup TS, Swartz MS, Davis SM, Lieberman JA.

Gen Hosp Psychiatry. 2009 Jan-Feb;31(1):1-7. Epub 2008 Oct 23.PMID: 19134502 [PubMed - indexed for MEDLINE]Related articles

Redox reactions of the non-heme iron in photosystem II: an EPR spectroscopic study.

McEvoy JP, Brudvig GW.

Biochemistry. 2008 Dec 16;47(50):13394-403.PMID: 19053286 [PubMed - indexed for MEDLINE]Related articles

Results of phase 3 of the CATIE schizophrenia trial.

Stroup TS, Lieberman JA, McEvoy JP, Davis SM, Swartz MS, Keefe RS, Miller AL, Rosenheck RA, Hsiao JK; CATIE Investigators.

Schizophr Res. 2009 Jan;107(1):1-12. Epub 2008 Nov 21.PMID: 19027269 [PubMed - indexed for MEDLINE]Related articles

Extrapyramidal side-effects of antipsychotics in a randomised trial.

Miller del D, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.

Br J Psychiatry. 2008 Oct;193(4):279-88.PMID: 18827289 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study.

Grossman I, Sullivan PF, Walley N, Liu Y, Dawson JR, Gumbs C, Gaedigk A, Leeder JS, McEvoy JP, Weale ME, Goldstein DB.

Genet Med. 2008 Oct;10(10):720-9.PMID: 18813134 [PubMed - indexed for MEDLINE]Related articles

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.

Daumit GL, Goff DC, Meyer JM, Davis VG, Nasrallah HA, McEvoy JP, Rosenheck R, Davis SM, Hsiao JK, Stroup TS, Lieberman JA.

Schizophr Res. 2008 Oct;105(1-3):175-87. Epub 2008 Sep 4.PMID: 18775645 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.

Swanson JW, Swartz MS, Van Dorn RA, Volavka J, Monahan J, Stroup TS, McEvoy JP, Wagner HR, Elbogen EB, Lieberman JA; CATIE investigators.

Br J Psychiatry. 2008 Jul;193(1):37-43.PMID: 18700216 [PubMed - indexed for MEDLINE]Related articlesFree article

Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.

Kinon BJ, Volavka J, Stauffer V, Edwards SE, Liu-Seifert H, Chen L, Adams DH, Lindenmayer JP, McEvoy JP, Buckley PF, Lieberman JA, Meltzer HY, Wilson DR, Citrome L.

J Clin Psychopharmacol. 2008 Aug;28(4):392-400.PMID: 18626265 [PubMed - indexed for MEDLINE]Related articles

Functional outcomes in schizophrenia.

McEvoy JP.

J Clin Psychiatry. 2008;69 Suppl 3:20-4. Review.PMID: 18533758 [PubMed - indexed for MEDLINE]Related articles

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

Meyer JM, Davis VG, McEvoy JP, Goff DC, Nasrallah HA, Davis SM, Daumit GL, Hsiao J, Swartz MS, Stroup TS, Lieberman JA.

Schizophr Res. 2008 Aug;103(1-3):104-9. Epub 2008 Jun 4.PMID: 18534821 [PubMed - indexed for MEDLINE]Related articlesFree article

Computational insights into the O2-evolving complex of photosystem II.

Sproviero EM, McEvoy JP, Gascón JA, Brudvig GW, Batista VS.

Photosynth Res. 2008 Jul;97(1):91-114. Epub 2008 May 16. Review.PMID: 18483777 [PubMed - indexed for MEDLINE]Related articlesFree article

A model of the oxygen-evolving center of photosystem II predicted by structural refinement based on EXAFS simulations.

Sproviero EM, Gascón JA, McEvoy JP, Brudvig GW, Batista VS.

J Am Chem Soc. 2008 May 28;130(21):6728-30. Epub 2008 May 6.PMID: 18457397 [PubMed - indexed for MEDLINE]Related articlesFree article

What CATIE found: results from the schizophrenia trial.

Swartz MS, Stroup TS, McEvoy JP, Davis SM, Rosenheck RA, Keefe RS, Hsiao JK, Lieberman JA.

Psychiatr Serv. 2008 May;59(5):500-6.PMID: 18451005 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA; Comparison of Atypicals in First Episode study group.

J Clin Psychiatry. 2008 Jan;69(1):106-13.PMID: 18312044 [PubMed - indexed for MEDLINE]Related articles

The costs of schizophrenia.

McEvoy JP.

J Clin Psychiatry. 2007;68 Suppl 14:4-7. Review.PMID: 18284271 [PubMed - indexed for MEDLINE]Related articles

Quantum mechanics/molecular mechanics study of the catalytic cycle of water splitting in photosystem II.

Sproviero EM, Gascón JA, McEvoy JP, Brudvig GW, Batista VS.

J Am Chem Soc. 2008 Mar 19;130(11):3428-42. Epub 2008 Feb 22.PMID: 18290643 [PubMed - indexed for MEDLINE]Related articles

Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Hill SK, Sweeney JA, Hamer RM, Keefe RS, Perkins DO, Gu H, McEvoy JP, Lieberman JA.

J Int Neuropsychol Soc. 2008 Mar;14(2):209-21.PMID: 18282319 [PubMed - indexed for MEDLINE]Related articles

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.

Meyer JM, Davis VG, Goff DC, McEvoy JP, Nasrallah HA, Davis SM, Rosenheck RA, Daumit GL, Hsiao J, Swartz MS, Stroup TS, Lieberman JA.

Schizophr Res. 2008 Apr;101(1-3):273-86. Epub 2008 Feb 6.PMID: 18258416 [PubMed - indexed for MEDLINE]Related articles

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller del D, McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA; CATIE Investigators.

Schizophr Res. 2008 Mar;100(1-3):39-52. Epub 2008 Jan 11.PMID: 18191383 [PubMed - indexed for MEDLINE]Related articles

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Essock SM, Finnerty M, Marder SR, Miller del D, McEvoy JP, Robinson DG, Schooler NR, Shon SP, Stroup TS, Miller AL.

J Clin Psychiatry. 2007 Nov;68(11):1751-62.PMID: 18052569 [PubMed - indexed for MEDLINE]Related articles

QM/MM computational studies of substrate water binding to the oxygen-evolving centre of photosystem II.

Sproviero EM, Shinopoulos K, Gascón JA, McEvoy JP, Brudvig GW, Batista VS.

Philos Trans R Soc Lond B Biol Sci. 2008 Mar 27;363(1494):1149-56; discussion 1156. Review.PMID: 17971333 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.

McEvoy JP, Daniel DG, Carson WH Jr, McQuade RD, Marcus RN.

J Psychiatr Res. 2007 Dec;41(11):895-905. Epub 2007 Jul 13.PMID: 17631314 [PubMed - indexed for MEDLINE]Related articles

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA.

Am J Psychiatry. 2007 Jul;164(7):1061-71.PMID: 17606658 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

McEvoy JP, Lieberman JA, Perkins DO, Hamer RM, Gu H, Lazarus A, Sweitzer D, Olexy C, Weiden P, Strakowski SD.

Am J Psychiatry. 2007 Jul;164(7):1050-60.PMID: 17606657 [PubMed - indexed for MEDLINE]Related articlesFree article

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.

Kim SY, Appelbaum PS, Swan J, Stroup TS, McEvoy JP, Goff DC, Jeste DV, Lamberti JS, Leibovici A, Caine ED.

Br J Psychiatry. 2007 Jul;191:38-43.PMID: 17602123 [PubMed - indexed for MEDLINE]Related articlesFree article

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA; CATIE Investigators; Neurocognitive Working Group.

Arch Gen Psychiatry. 2007 Jun;64(6):633-47.PMID: 17548746 [PubMed - indexed for MEDLINE]Related articlesFree article

The importance of early treatment of schizophrenia.

McEvoy JP.

Behav Healthc. 2007 Apr;27(4):40-3.PMID: 17536387 [PubMed - indexed for MEDLINE]Related articles

Quantum mechanics/molecular mechanics structural models of the oxygen-evolving complex of photosystem II.

Sproviero EM, Gascón JA, McEvoy JP, Brudvig GW, Batista VS.

Curr Opin Struct Biol. 2007 Apr;17(2):173-80. Epub 2007 Mar 28. Review.PMID: 17395452 [PubMed - indexed for MEDLINE]Related articles

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Reimherr F, McGee MF, Keefe RS, McEvoy JP, Hsiao JK, Lieberman JA; CATIE Investigators.

Am J Psychiatry. 2007 Mar;164(3):428-36.PMID: 17329467 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2007 Mar;164(3):415-27.PMID: 17329466 [PubMed - indexed for MEDLINE]Related articlesFree article

Catatonic coma with profound bradycardia.

Freudenreich O, McEvoy JP, Goff DC, Fricchione GL.

Psychosomatics. 2007 Jan-Feb;48(1):74-8.PMID: 17209155 [PubMed - indexed for MEDLINE]Related articlesFree article

Water-splitting chemistry of photosystem II.

McEvoy JP, Brudvig GW.

Chem Rev. 2006 Nov;106(11):4455-83. Review. No abstract available. PMID: 17091926 [PubMed - indexed for MEDLINE]Related articles

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods.

Aliyu MH, Calkins ME, Swanson CL Jr, Lyons PD, Savage RM, May R, Wiener H, McLeod-Bryant S, Nimgaonkar VL, Ragland JD, Gur RE, Gur RC, Bradford LD, Edwards N, Kwentus J, McEvoy JP, Santos AB, McCleod-Bryant S, Tennison C, Go RC, Allen TB; PAARTNERS Study Group.

Schizophr Res. 2006 Oct;87(1-3):32-44. Epub 2006 Aug 2. Erratum in: Schizophr Res. 2007 Feb;90(1-3):369. Allen, Trina B [added]; Devlin, Bernie [corrected to McLeod-Bryant, Stephen]. PMID: 16887335 [PubMed - indexed for MEDLINE]Related articles

Olanzapine and haloperidol in first episode psychosis: two-year data.

Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, Tohen MF, Woolson S, Zipursky RB; HGDH Study Group.

Schizophr Res. 2006 Sep;86(1-3):234-43. Epub 2006 Aug 2.PMID: 16887334 [PubMed - indexed for MEDLINE]Related articles

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.

Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, Lieberman JA.

Schizophr Res. 2006 Sep;86(1-3):15-22. Epub 2006 Aug 1.PMID: 16884895 [PubMed - indexed for MEDLINE]Related articles

Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, McGee M, Miller del D, Reimherr F, Khan A, Cañive JM, Lieberman JA.

Psychiatr Serv. 2006 Aug;57(8):1110-6.PMID: 16870961 [PubMed - indexed for MEDLINE]Related articlesFree article

Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia.

Chwastiak LA, Rosenheck RA, McEvoy JP, Keefe RS, Swartz MS, Lieberman JA.

Psychiatr Serv. 2006 Aug;57(8):1102-9.PMID: 16870960 [PubMed - indexed for MEDLINE]Related articlesFree article

Risks versus benefits of different types of long-acting injectable antipsychotics.

McEvoy JP.

J Clin Psychiatry. 2006;67 Suppl 5:15-8. Review.PMID: 16822092 [PubMed - indexed for MEDLINE]Related articles

An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

McEvoy JP.

CNS Spectr. 2006 Jul;11(7 Suppl 7):4-8. No abstract available. PMID: 16816794 [PubMed - indexed for MEDLINE]Related articlesFree article

Insight in first-episode psychosis.

McEvoy JP, Johnson J, Perkins D, Lieberman JA, Hamer RM, Keefe RS, Tohen M, Glick ID, Sharma T.

Psychol Med. 2006 Oct;36(10):1385-93. Epub 2006 Jun 2.PMID: 16740175 [PubMed - indexed for MEDLINE]Related articles

A national study of violent behavior in persons with schizophrenia.

Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup TS, McEvoy JP, Lieberman JA.

Arch Gen Psychiatry. 2006 May;63(5):490-9.PMID: 16651506 [PubMed - indexed for MEDLINE]Related articlesFree article

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller del D, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA.

Neuropsychopharmacology. 2006 Sep;31(9):2033-46. Epub 2006 Apr 19.PMID: 16641947 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):611-22.PMID: 16585435 [PubMed - indexed for MEDLINE]Related articlesFree article